Discovery of 4-((2S,5R)-2-((difluoromethoxy)methyl)-5-(4-(trifluoromethyl)phenyl)piperidin-1-yl)-N-((R)-1-(4-(ethylsulfonyl)phenyl)-2-hydroxyethyl)benzamide as a potent, orally available RORγt inverse agonist
已完结10由 小新 发布于 2026/7/28 12:44:41
DOI:10.1016/j.bioorg.2026.109959
作者:Wei Cao ,?Bing Liu ,?Ning Kang ,?Shun Bai ,?Feng Wang ,?Lixuan Xue ,?Minxiong Li ,?Cliff C. Cheng ,?Fang Yang ,?Yingjun Zhang ,?Xiaoyun Lu
文献类型:期刊论文
补充材料:只需要正文